Table 3.
Association between immune markers and cumulative incidence of recurrence in octogenarians (n = 151)
| Total | ||||
|---|---|---|---|---|
| Variable | No. | (%) | 5-Year CIR* | P |
| CD3 | 0.92 | |||
| Low | 63 | (45) | 22% | |
| High | 78 | (55) | 23% | |
| CD4 | 0.7 | |||
| Low | 36 | (47) | 25% | |
| High | 41 | (53) | 24% | |
| CD8 | 0.99 | |||
| Low | 44 | (57) | 26% | |
| High | 33 | (43) | 23% | |
| CD20 | 0.86 | |||
| Low | 52 | (68) | 27% | |
| High | 25 | (32) | 21% | |
| CD45RO | 0.38 | |||
| Low | 65 | (47) | 21% | |
| High | 74 | (53) | 25% | |
| FoxP3 | 0.094 | |||
| Low | 64 | (45) | 15% | |
| High | 78 | (55) | 30% | |
| CD68 | 0.017 | |||
| Low | 15 | (20) | 54% | |
| High | 60 | (80) | 18% | |
| FoxP3/CD3 ratio | 0.021 | |||
| High/Low | 19 | (13) | 17% | |
| Others | 122 | (87) | 56% | 0.53 |
| FoxP3/CD4 ratio | ||||
| High/High | 32 | (42) | 28% | |
| Others | 45 | (58) | 17% | |
| CD4/CD8 ratio | 0.6 | |||
| High/Low | 26 | (34) | 24% | |
| Others | 51 | (66) | 25% | |
*CIR, Cumulative Incidence of Recurrence
Significant P-values (<0.05) are shown in bold type